Am J Surg

1. SHEN N, Ramanathan S, Horns JJ, Hyngstrom JR, et al
   Corrigendum to "The benefit of sentinel lymph node biopsy in elderly patients with melanoma: A retrospective analysis of SEER-Medicare data (2010-2018)" [Am J Surg 237 (2024) 115896].
   Am J Surg. 2026 May 21:117041. doi: 10.1016/j.amjsurg.2026.117041.
   

   >> Share

   
   

   
   Ann Surg Oncol

2. KENNEY LM, Dinerman AJ, Gustafson AM, Hakim AA, et al
   Liver Metastasectomy to Obtain Tumor-Infiltrating Lymphocytes: Technical Considerations and Report on Single-Center Experience.
   Ann Surg Oncol. 2026;33:5791-5800.
   

   >> Share

   
   

   
   BMC Cancer

3. ALQAISI O, Al-Ghabeesh S, Ali BA, Tai P, et al
   Sexual dysfunction among melanoma survivors: a scoping review of current evidence and clinical gaps.
   BMC Cancer. 2026 May 18. doi: 10.1186/s12885-026-16177.
   

   >> Share

   
   

   
   Br J Dermatol

4. THOMAS NE, Kanetsky PA
   Enhanced Polygenic Risk Scores for Melanoma Prediction.
   Br J Dermatol. 2026 May 21:ljag185. doi: 10.1093.
   

   >> Share

   
   
5. COLLARD MK, Belkadi-Sadou D, Cavalcanti A, Lesourd R, et al
   Immune checkpoint inhibitors in anorectal melanoma: has it changed the outcomes?
   Br J Dermatol. 2026 May 20:ljag204. doi: 10.1093.
   

   >> Share

   
   
6. KIPS J, Papeleu J, Shen A, Mylle S, et al
   Artificial intelligence-based smartphone application for skin cancer detection: A prospective diagnostic accuracy study.
   Br J Dermatol. 2026 Feb 17:ljag057. doi: 10.1093.
   

   >> Share

   
   
7. 
   Correction to: A national cohort study of melanoma BRAF status, testing patterns, patient and tumour characteristics, treatment and survival in England from 2016 to 2021.
   Br J Dermatol. 2026 May 21:ljag197. doi: 10.1093.
   

   >> Share

   
   

   
   Cancer Res

8. FOTH M, Kim W, O'Toole K, Murphy B, et al
   Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS-Mutated Melanoma.
   Cancer Res. 2026 May 22. doi: 10.1158/0008-5472.CAN-26-1313.
   

   >> Share

   
   

   
   Clin Cancer Res

9. GRANHOJ JS, Mannering SMH, Madsen K, W Hendel H, et al
   Phenotypic and Functional Characteristics of CD8+ T cells Predict Clinical Outcome Following TIL Therapy in a Randomized Phase III Trial in Advanced Melanoma.
   Clin Cancer Res. 2026 May 18. doi: 10.1158/1078-0432.CCR-25-4097.
   

   >> Share

   
   

   
   Int J Cancer

10. GEIDEL G, Lowinus T, Metzger P, Czurda R, et al
    Molecular Tumor Boards in Malignant Melanoma: Uncovering Challenges and Opportunities in a Bicenter Retrospective Analysis in Germany.
    Int J Cancer. 2026 May 15. doi: 10.1002/ijc.70554.
    

    >> Share

    
    

    
    J Am Acad Dermatol

11. TRAN HTT, Le DV, Shrestha R, Wetter DA, et al
    Racial Disparities in Survival Among Patients with Vulvar Melanoma: A National Cancer Database Analysis.
    J Am Acad Dermatol. 2026 May 19:S0190-9622(26)02716.
    

    >> Share

    
    
12. LUO Z, Guo Z, Zhang S, Chen Y, et al
    Temporal Trends and Contributing Factors of Racial and Ethnic Disparities in Cutaneous Melanoma Survival: A SEER database analysis.
    J Am Acad Dermatol. 2026 May 18:S0190-9622(26)02667.
    

    >> Share

    
    
13. KASHERI E, Dan J, Nouri K
    Higher Dermatologist Density Is Associated with Lower Proportions of Late-Stage Melanoma: An Ecological Study of the State Cancer Profiles.
    J Am Acad Dermatol. 2026 May 16:S0190-9622(26)02665.
    

    >> Share

    
    
14. YU H, Ma J, Lin P, Li H, et al
    Trends and projections of the melanoma burden in G20 countries: A comprehensive analysis from the Global Burden of Disease Study, 1990-2023.
    J Am Acad Dermatol. 2026 May 15:S0190-9622(26)02659.
    

    >> Share

    
    
15. YONAS N, Chang AY, Tetzlaff M, Klufas DM, et al
    Nail Unit Acral Melanoma Shows Disproportionate Ulceration Compared with Non-Nail Acral Melanoma.
    J Am Acad Dermatol. 2026 May 15:S0190-9622(26)02660.
    

    >> Share

    
    
16. PEREZ D, Kim DY, Hartman RI
    Cutaneous Melanoma Incidence by Thickness Before and During the COVID-19 Pandemic Using the SEER Program: Early-Stage Rebound.
    J Am Acad Dermatol. 2026 May 14:S0190-9622(26)02651.
    

    >> Share

    
    
17. ROLAND-MCGOWAN JN, Ose OM, Yu Y, Latour E, et al
    Quantitative versus qualitative risk framing in patient decision aids for dysplastic nevi: A randomized A/B testing study.
    J Am Acad Dermatol. 2026;94:1697-1704.
    

    >> Share

    
    

    
    Melanoma Res

18. BLOCK BR, Mehta J, Powers CM, Ungar J, et al
    Pregnancy and risk of melanoma: a matched retrospective cohort study.
    Melanoma Res. 2026 May 22. doi: 10.1097/CMR.0000000000001109.
    

    >> Share

    
    
19. ALIZADA S, Al Qudah H, Vu T, Stewart J, et al
    Ultrasound imaging features of cervical lymph nodes with melanoma metastasis compared with benign cervical nodes.
    Melanoma Res. 2026 May 22. doi: 10.1097/CMR.0000000000001107.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share